Navamedic ASA (N1A) Financial Statements
Navamedic ASA Financial Overview
Navamedic ASA's market cap is currently $25.99M. The company's EPS TTM is $-1.03; its P/E ratio is -11.55; Navamedic ASA is estimated to report earnings on February 12, 2027, and the estimated EPS forecast is $0.00. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 565.36M | $ 531.44M | $ 512.00M | $ 382.13M | $ 278.44M |
| Gross Profit | $ 188.97M | $ 208.88M | $ 199.05M | $ 163.52M | $ 111.74M |
| Operating Income | $ 16.25M | $ 24.13M | $ 23.58M | $ 50.76M | $ 4.86M |
| EBITDA | $ 47.61M | $ 46.55M | $ 37.09M | $ 54.27M | $ 16.68M |
| Net Income | $ -23.54M | $ 1.29M | $ 3.30M | $ 29.43M | $ 618.00K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 83.45M | $ 53.48M | $ 38.04M | $ 64.39M | $ 51.70M |
| Total Assets | $ 741.75M | $ 491.24M | $ 524.30M | $ 382.77M | $ 330.18M |
| Total Debt | $ 227.36M | $ 139.93M | $ 173.74M | $ 62.70M | $ 54.81M |
| Net Debt | $ 153.21M | $ 102.65M | $ 135.70M | $ 8.40M | $ 3.12M |
| Total Liabilities | $ 407.67M | $ 250.81M | $ 301.91M | $ 173.05M | $ 178.94M |
| Stockholders' Equity | $ 334.08M | $ 240.44M | $ 222.39M | $ 209.72M | $ 151.24M |
| Cash Flow | |||||
| Free Cash Flow | $ 23.20M | $ 38.36M | $ -19.00K | $ 15.69M | $ -2.03M |
| Operating Cash Flow | $ 25.59M | $ 39.35M | $ 2.18M | $ 17.94M | $ -1.30M |
| Investing Cash Flow | $ -186.65M | $ -2.78M | $ -104.58M | $ -25.44M | $ -727.00K |
| Financing Cash Flow | $ 197.00M | $ -37.74M | $ 83.23M | $ 10.07M | $ 15.93M |
Currency in NOK
